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Dear Sir,
In the May issue of the Netherlands Heart Journal, we
published an update [1] of a previous bibliometric analysis
of the scientific work of Dutch professors in clinical
cardiology [2]. The paper was accompanied by an editorial
[3] in the same issue and another one in the subsequent
June issue [4].
V an der Wall [3] summarises our paper and emphasises
that we have stated ‘….that citation analysis should always
be applied with great care in science policy.’ We indeed
concluded that given the inhomogeneity in citation charac-
teristics of the scientific output of an -at first sight-
homogeneous group of clinical cardiologists, such analyses
lack sufficient validation for application in a more complex
network as a university medical centre. In his 2005 paper
[5], Hirsch indeed proposed his well-known h-index for
quality assessment of scientific output. At that time he
emphasised that Nobel prize winners had h-indices of 30
and higher. In addition he mentioned that a h-index of 18
might be reasonable as an equivalent for a full-
professorship, whereas a h-index of 10–12 might be
reasonable to obtain ‘tenure’. It is important to underscore
that Hirsch’s statements were restricted to the arena of
physics, where h-indices are much lower than in the life
sciences, as pointed out previously by us [2] and others [6].
Professor Doevendans’ contribution [4] focuses on the
competitive aspects of science in relation with its financial
system rather than on our paper [1]. We fully agree with
Doevendans that the credibility of a funding system is very
important. A system primarily based on grants heavily leans
on the integrity of committees and individuals deciding on
the fate of research proposals. With respect to this the
literature is not very reassuring to put it mildly [7–9]. There
is a trend towards decision-making at an early stage (within
academic medical centres; i.e. before actual submission)
and to decision-making without peer review after submis-
sion. Despite the understandable efforts to save time and
energy both on the part of applicants and those in control of
the system, we share the concerns of Professor Doevendans
[4]. Therefore we can imagine that bibliometric analysis
can be perceived as part of an armamentarium in a tombola
with unequal chances and is therefore received with
distrust.
Having said that, we must take away from three of
Doevendans’ suggestions. 1) Authors with an uncommon
name had a disadvantage of up to 20%, whereas data of
authors with ‘a more common name’ were polluted. It is
suggested that we allocated citations or papers to professors
that they did not receive, respectively write. In case of
doubt, our data were checked on a per author/per paper
base. Therefore our data stand! However, in general,
Professor Doevendans is correct in emphasising that when
an assessment is made by organisations/institutions that do
not know the individuals/work under assessment, there is
an increased risk for errors. This implies that an adversary
approach is always wise. But again, this is not the case in
our study. 2) Doevendans’ claim that the use of alternative
databases as Scopus (or e.g. Google Scholar) instead of
Thomson Reuters’ Web of Science (WoS) would lead to
different rankings is not substantiated with data. However,
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rankings. Some databases index more journals than others
and with different time lags as well. To us it seems
improbable that individuals in any top-10 based on the
Thomson Reuters’ database would not score high in the
other databases as well. But the onus to show this is not on
us, but on those who criticise our study. 3) Doevendans
states that ‘although the paper is accepted by a scientific
journal, the reproducibility of the data has not been
established.’ This is simply not true because a second
count of several authors, using the same database (i.e. WoS),
revealed identical results. Within one and the same
database, the data are reproducible.
It is a pity that Professor Doevendans focuses on
differences between the databases without an effort to
either measure or explain these. In addition, there is some
juggling with the concept of ‘reproducibility’. This tends to
obscure the quintessence of our paper: large differences in
citations and also in h-indices occur within a relatively
homogeneous group of clinical cardiologists. These differ-
ences cannot be interpreted as differences in scientific
quality, because we have shown that there are large
differences in citation frequency, e.g. between ‘sub-sub-
fields’ as ‘Marfan syndrome’ and ‘Brugada syndrome’, but
also between ‘subfields’ as ‘congenital heart disease’ and
‘arrhythmias’, just to mention a few. Thus, this type of
citation analysis at the personal level should be discour-
aged, because it can damage the scientific status of
individuals. It goes without saying that this advice is even
more urgent when it comes to comparison of different
specialisations within university medical centres, where
these are meant to corroborate each other.
We finish by summarising three important parameters
that determine the total of citations of a scientist. First is the
network. How many co-authors (and grants…)w e r e
involved? Second is the ‘citation culture’. In medicine,
papers have many more references than in mathematics or
computer science. We would not want to see a mathematics
faculty closed down because the h-indices of its scientists
are considered too low (compared with the medicine
faculty). Third is the number of scientists publishing in a
field. If an author publishes a paper and there are 10 other
scientists active and publishing in the same field, whose
papers all cite the work, the author under assessment
obtains ‘only’ 10 citations, despite the fact that 100% of the
citing authors have cited the work. If there are 100 other
scientists of which 50 cite the work, the author under
assessment obtains 50 citations (five times as many)
although ‘only’ 50% of the citing authors have cited the
work. These three issues, in particular the last one, have
thus far not been fully addressed in the specialised literature
in such a way that consensus resulted.
There is an additional concern. When an identical paper
is simultaneously published in two or more journals, the
citations obtained are not identical, but strongly correlated
with the impact factor of the publishing journal [10]. The
difference can be substantial. How then can citations be
taken as a parameter of scientific quality?
For all these reasons we concluded that ‘citation analysis
should be applied with great care in science policy’. And
not because our data are incorrect or not reproducible.
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